These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3441484)
1. The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity. Riedel A; Braquet P; Mest HJ Pharmacol Res Commun; 1987 Oct; 19(10):703-12. PubMed ID: 3441484 [TBL] [Abstract][Full Text] [Related]
2. Antagonists of PAF and histamine inhibit ouabain-induced cardiac arrhythmias in sensitized guinea-pigs. Mest HJ; Rein T; Riedel A Pol J Pharmacol Pharm; 1990; 42(3):283-9. PubMed ID: 2263535 [TBL] [Abstract][Full Text] [Related]
3. Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion. Koltai M; Tosaki A; Hosford D; Braquet P Eur J Pharmacol; 1989 May; 164(2):293-302. PubMed ID: 2759177 [TBL] [Abstract][Full Text] [Related]
4. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids. Mest HJ; Riedel A; Braquet P; Meyer E Biomed Biochim Acta; 1988; 47(10-11):S219-23. PubMed ID: 3248107 [TBL] [Abstract][Full Text] [Related]
5. WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity. Mest HJ; Riedel A; Rein T Pharmacol Res; 1990; 22(4):445-53. PubMed ID: 2402478 [TBL] [Abstract][Full Text] [Related]
6. Effect of BN 52256 and other mediator antagonists on ouabain-induced cardiac arrhythmia in a model of anaphylaxis in guinea-pigs. Mest HJ; Hörhold I; Rein T; Riedel A; Broquet C Pharmacol Res; 1992; 25(2):173-80. PubMed ID: 1635894 [TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig. Touvay C; Vilain B; Lejeune V; Mencia-Huerta JM; Braquet P Biochem Biophys Res Commun; 1989 Aug; 163(1):118-23. PubMed ID: 2775253 [TBL] [Abstract][Full Text] [Related]
8. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901 [TBL] [Abstract][Full Text] [Related]
9. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021. Baranes J; Hellegouarch A; Le Hegarat M; Viossat I; Auguet M; Chabrier PE; Braquet P Pharmacol Res Commun; 1986 Aug; 18(8):717-37. PubMed ID: 3763677 [TBL] [Abstract][Full Text] [Related]
10. Effects of platelet activating factor (PAF) and its receptor antagonist BN 52021 on isolated perfused guinea-pig heart. Viossat I; Chapelat M; Chabrier PE; Braquet P Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):189-94. PubMed ID: 2622972 [TBL] [Abstract][Full Text] [Related]
11. Cellular electrophysiological effects of platelet-activating factor (PAF) and its antagonist BN 52021 in cardiac preparations. Kecskemeti V; Braquet P Drugs Exp Clin Res; 1992; 18(1):9-16. PubMed ID: 1600866 [TBL] [Abstract][Full Text] [Related]
12. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis. Berti F; Omini C; Rossoni G; Braquet P Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317 [TBL] [Abstract][Full Text] [Related]
13. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity. Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659 [TBL] [Abstract][Full Text] [Related]
14. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin. Dixon EJ; Wilsoncroft P; Robertson DN; Page CP Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238 [TBL] [Abstract][Full Text] [Related]
15. [Ginkgolides antagonizing some effects of platelet-activating factor in vitro]. Dong JC; Li M; Shi ZY Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):606-8. PubMed ID: 8704427 [TBL] [Abstract][Full Text] [Related]
16. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs. Lagente V; Boichot E; Carre C; Guinot P; Mencia-Huerta JM; Braquet P Clin Exp Allergy; 1993 Dec; 23(12):1002-10. PubMed ID: 10779293 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs. Qian C; Guo ZM; Peters CJ; Liu CT J Lipid Mediat; 1993 Jul; 7(3):223-37. PubMed ID: 8219003 [TBL] [Abstract][Full Text] [Related]
18. [Experimental study on antagonism of ginkgolides against effect of platelet-activating factor on lung strip of guinea pigs]. Dong JC; Li M; Wu GT Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Aug; 17(8):481-3, 502. PubMed ID: 10322836 [TBL] [Abstract][Full Text] [Related]
19. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study. Kecskeméti V; Balogh I J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945 [TBL] [Abstract][Full Text] [Related]
20. Effects of platelet activating factor on contractile force and 45Ca fluxes in guinea-pig isolated atria. Diez J; Delpón E; Tamargo J Br J Pharmacol; 1990 Jun; 100(2):305-11. PubMed ID: 2379035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]